EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor

Shengnan Liu, Haoran Chen, Qi Wu, Yan Sun, Yu Pei, Ziwei Wang, Dongxia Zhu iD, Gungzhe Li, Martin R Bryce iD, Yulei Chang iD

Inorganic Chemistry · 2024

DOI: 10.1021/acs.inorgchem.4c02399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Shengnan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Department of Chemistry, Northeast Normal University, 5268 Re…. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Iridium. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, China Postdoctoral Science Foundation, Changchun Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limited optical penetration depth and hypoxic tumor microenvironment (TME) are key factors that hinder the practical applications of conventional photodynamic therapy (PDT). To fundamentally address these issues, self-luminescent photosensitizers (PSs) can achieve efficient PDT. Herein, a self-chemiluminescence (CL)-triggered Ir complex PS, namely, IrL2, with low-O2-dependence type I photochemical processes is reported for efficient PDT. The rational design achieves efficient chemiluminescence resonance energy transfer (CRET) from covalently bonded luminol units to the Ir complex in IrL2 under the catalysis of H2O2 and hemoglobin (Hb) to generate O2•- and 1O2. Liposome IrL2H nanoparticles (NPs) are constructed by loading IrL2 and Hb. The intracellular H2O2 and loaded Hb catalyze the luminol part of IrL2H, and the Ir2 part is then excited to produce types I and II reactive oxygen species (ROS) through CRET, inducing cell death, even under hypoxic conditions, and promoting cell apoptosis. IrL2H is used for tumor imaging and inhibits tumor growth in 4T1-bearing mouse models through intratumoral injection without external light sources. This work provides new designs for transition metal complex PSs that conquer the limitations of external light sources and the hypoxic TME in PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsIridiumAnimalsMiceCoordination ComplexesLuminescenceAntineoplastic AgentsApoptosisHumansMice, Inbred BALB CCell Line, TumorDrug Screening Assays, AntitumorTumor HypoxiaCell ProliferationFemaleCell SurvivalReactive Oxygen SpeciesMolecular Structure

Substanzen

Photosensitizing AgentsIridiumCoordination ComplexesAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Department of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, Jilin Province 130024, P. R. China.
  • State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun, Jilin Province 130033, P. R. China.
  • Jilin Provincial Science and Technology Innovation Center of Health Food of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin Province 130117, P. R. China.
  • Department of Chemistry, Durham University, Durham DH1 3LE, U.K.

ORCID-Profile: Dongxia Zhu, Martin R Bryce, Yulei Chang

Förderung

  • Engineering and Physical Sciences Research Council
  • China Postdoctoral Science Foundation
  • Changchun Science and Technology Bureau
  • Department of Science and Technology of Jilin Province
  • Jilin Province Development and Reform Commission
  • National Natural Science Foundation of China

Zitieren

APA

Liu, S., Chen, H., Wu, Q., Sun, Y., Pei, Y., Wang, Z., Zhu, D., Li, G., Bryce, M. R., & Chang, Y. (2024). Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c02399

Vancouver

Liu S, Chen H, Wu Q, Sun Y, Pei Y, Wang Z, et al. Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.4c02399

BibTeX
@article{Liu2024,
  author = {Liu, Shengnan and Chen, Haoran and Wu, Qi and Sun, Yan and Pei, Yu and Wang, Ziwei and Zhu, Dongxia and Li, Gungzhe and Bryce, Martin R and Chang, Yulei},
  title = {Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor},
  journal = {Inorganic Chemistry},
  year = {2024},
  doi = {10.1021/acs.inorgchem.4c02399}
}
Kostenlos starten →